Mary Mosher

Array ( [id] => 8755238 [patent_doc_number] => 20130089543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'MONOCLONAL ANTIBODIES THAT BIND OR NEUTRALIZE DENGUE VIRUS' [patent_app_type] => utility [patent_app_number] => 13/692521 [patent_app_country] => US [patent_app_date] => 2012-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 39394 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9771230 [patent_doc_number] => 20140294893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'RECOMBINANT NONPATHOGENIC MDV VECTOR PROVIDING MULTIVALENT IMMUNITY' [patent_app_type] => utility [patent_app_number] => 14/351739 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17175 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903686 [patent_doc_number] => 20130171189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'INDUCIBLE AND REPRESSIBLE VACCINIA VIRUSES WITH IMPROVED SAFETY' [patent_app_type] => utility [patent_app_number] => 13/652015 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14146 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13652015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10191875 [patent_doc_number] => 09220769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Composition' [patent_app_type] => utility [patent_app_number] => 14/346669 [patent_app_country] => US [patent_app_date] => 2012-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 11192 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659062 [patent_doc_number] => 20130039891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'POXVIRAL ONCOLYTIC VECTORS' [patent_app_type] => utility [patent_app_number] => 13/620983 [patent_app_country] => US [patent_app_date] => 2012-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12482 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585676 [patent_doc_number] => 20130004497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'MONOCLONAL ANTIBODIES SPECIFIC TO HEMAGGLUTININ AND NEURAMINIDASE FROM INFLUENZA VIRUS H5-SUBTYPE OR N1-SUBTYPE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/610054 [patent_app_country] => US [patent_app_date] => 2012-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12506 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13610054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585676 [patent_doc_number] => 20130004497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'MONOCLONAL ANTIBODIES SPECIFIC TO HEMAGGLUTININ AND NEURAMINIDASE FROM INFLUENZA VIRUS H5-SUBTYPE OR N1-SUBTYPE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/610054 [patent_app_country] => US [patent_app_date] => 2012-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12506 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13610054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585675 [patent_doc_number] => 20130004496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'MONOCLONAL ANTIBODIES SPECIFIC TO HEMAGGLUTININ AND NEURAMINIDASE FROM INFLUENZA VIRUS H5-SUBTYPE OR N1-SUBTYPE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/610021 [patent_app_country] => US [patent_app_date] => 2012-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12508 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13610021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9015588 [patent_doc_number] => 20130230552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES' [patent_app_type] => utility [patent_app_number] => 13/594611 [patent_app_country] => US [patent_app_date] => 2012-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 25936 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13594611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8707554 [patent_doc_number] => 20130064844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'NON-SPLICING VARIANTS OF GP350/220' [patent_app_type] => utility [patent_app_number] => 13/591513 [patent_app_country] => US [patent_app_date] => 2012-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10350 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13591513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989290 [patent_doc_number] => 20130216572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'IMMEDIATE PROTECTION AGAINST PATHOGENS VIA MVA' [patent_app_type] => utility [patent_app_number] => 13/589273 [patent_app_country] => US [patent_app_date] => 2012-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16632 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13589273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8975969 [patent_doc_number] => 20130209399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'ANTI-VIRUS THERAPY FOR RESPIRATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 13/587752 [patent_app_country] => US [patent_app_date] => 2012-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 28098 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891145 [patent_doc_number] => 20130164330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'Methods and Compositions for Treatment of Hematologic Cancers' [patent_app_type] => utility [patent_app_number] => 13/555615 [patent_app_country] => US [patent_app_date] => 2012-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15811 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13555615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9097338 [patent_doc_number] => RE044558 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2013-10-22 [patent_title] => 'Chromatographic method for high yield purification and viral inactivation of antibodies' [patent_app_type] => reissue [patent_app_number] => 13/553364 [patent_app_country] => US [patent_app_date] => 2012-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6333 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9615765 [patent_doc_number] => 20140205621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'CANINE CORONAVIRUS VACCINE' [patent_app_type] => utility [patent_app_number] => 14/127884 [patent_app_country] => US [patent_app_date] => 2012-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10148 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495488 [patent_doc_number] => 20120294896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Methods and Compositions for Poxvirus A35R Protein' [patent_app_type] => utility [patent_app_number] => 13/491356 [patent_app_country] => US [patent_app_date] => 2012-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21269 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9344837 [patent_doc_number] => 08663984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Non-simian cells for growth of porcine reproductive and respiratory syndrome (PRRS) virus' [patent_app_type] => utility [patent_app_number] => 13/475444 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13959 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626003 [patent_doc_number] => 08795678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'TLR-2 agonists and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/470554 [patent_app_country] => US [patent_app_date] => 2012-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5748 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815363 [patent_doc_number] => 20130116408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy' [patent_app_type] => utility [patent_app_number] => 13/469934 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7306 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13469934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777406 [patent_doc_number] => 08852607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith' [patent_app_type] => utility [patent_app_number] => 13/506638 [patent_app_country] => US [patent_app_date] => 2012-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8961 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13506638 [rel_patent_id] =>[rel_patent_doc_number] =>)